RootPath的核心技术优势，在于其功能强大的新靶点发现平台。 该平台能提供包括单细胞分析、肿瘤诊断和免疫治疗在内的多项服务，覆盖众多当前 ...

1月6日，生物科技公司RootPath宣布完成1100万美元A轮融资。本轮融资由由经纬中国、元禾原点共同领投。 作为本轮领投方，经纬中国董事总经理喻志云 ...

RootPath Custom Gene Library was launched in China earlier this year and was met with broad enthusiasm. RootPath has already commercially delivered thousands of genes to its early-adopter customers.

联系电话：4009950930 关注呈源生物（RootPath）公众号 关于呈源生物 呈源生物（RootPath）是一家专注于基因合成和解码免疫系统的合成生物学和细胞 ...

合成生物学与基因细胞治疗公司呈源生物（RootPath）近日完成近5000万美元B轮融资，本轮融资由云九资本、鼎晖投资共同领投，弘毅生命科学基金跟投 ...

（中国-广州）呈源生物（RootPath）今天宣布在中国推出基因合成领域的创新性产品 -呈源定制基因库，以序列验证后的单个质粒（plasmid）作为交付 ...

RootPath was launched by Nest.Bio Ventures in 2017 and has raised $18M in seed and Series A financing. RootPath is located in Cambridge, MA with additional research activities at two sites in China.

RootPath was incubated and founded by Nest.bio Ventures in 2017 and has since raised more than $60 million from renowned investors such as Sequoia Capital China, CDH Investment and Sky9 Capital.

RootPath offers a range of plasmid vectors, including standard vectors like pUC19, pET-11a, as well as customer-provided ones. Currently, standard RootPath Custom Gene Library supports gene ...

Article ‘Count’ and ‘Share’ for Rootpath - China based on listed parameters only. The articles listed below published by authors from Rootpath - China, organized by journal and article ...